Results 101 to 110 of about 2,273 (120)

[Cancer prevention recommendations: Update 2024]. [PDF]

open access: yesAten Primaria
Bartolomé-Moreno C   +7 more
europepmc   +1 more source

[Flagellate erythema secondary to bleomycin: case report with favorable outcome]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Leal-León R   +4 more
europepmc   +1 more source

[Prevalence of unexpected malignant disease in the histopathology of hysterectomy indicated for benign condition]. [PDF]

open access: yesRev Colomb Obstet Ginecol
Sanchez Mayorca I   +3 more
europepmc   +1 more source

Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer [PDF]

open access: yesRev Colomb Obstet Ginecol
Pierre ME   +11 more
europepmc   +1 more source

Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer [PDF]

open access: yesRev Colomb Obstet Ginecol
Vázquez Rojo J   +2 more
europepmc   +1 more source

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. [PDF]

open access: yesGynecol Oncol
Washington C   +15 more
europepmc   +1 more source

The ‘how’ and ‘why’ of qualitative research in health [PDF]

open access: yesRev Colomb Obstet Ginecol
Briceño-Morales X, Briceño-Morales C.
europepmc   +1 more source

Home - About - Disclaimer - Privacy